2 Value Stocks with Promising Prospects and 1 That Underwhelm
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. Keeping that in mind, here are two value stocks trading at big discounts to their intrinsic values and one with little support.
One Value Stock to Sell:
Weatherford (WFRD)
Forward P/E Ratio: 14.7x
Operating in roughly 75 countries with over 300 facilities worldwide, Weatherford (NASDAQ:WFRD) provides equipment and services for drilling, completing, and maintaining oil and gas wells.
Why Are We Cautious About WFRD?
- Annual sales declines of 5.1% for the past ten years show its products and services struggled to connect with the market during this cycle
- Gross margin of 31.7% is below its competitors, leaving less money to invest in exploration and production
At $83.00 per share, Weatherford trades at 14.7x forward P/E. To fully understand why you should be careful with WFRD, check out our full research report (it’s free).
Two Value Stocks to Watch:
First Solar (FSLR)
Forward P/E Ratio: 11.7x
Headquartered in Arizona, First Solar (NASDAQ:FSLR) specializes in manufacturing solar panels and providing photovoltaic solar energy solutions.
Why Will FSLR Beat the Market?
- Market share has increased this cycle as its 23.3% annual revenue growth over the last two years was exceptional
- Free cash flow profile has moved into positive territory over the last five years, showing the company is at an important crossroads
- Rising returns on capital show management is finding more attractive investment opportunities
First Solar’s stock price of $228.75 implies a valuation ratio of 11.7x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Zoetis (ZTS)
Forward P/E Ratio: 10.8x
Originally spun off from Pfizer in 2013 as the world's largest pure-play animal health company, Zoetis (NYSE:ZTS) discovers, develops, and sells medicines, vaccines, diagnostic products, and services for pets and livestock animals worldwide.
Why Are We Positive on ZTS?
- Constant currency growth averaged 8.7% over the past two years, showing it can expand globally regardless of the macroeconomic environment
- Robust free cash flow margin of 21.3% gives it many options for capital deployment, and its recently improved profitability means it has even more resources to invest or distribute
- Industry-leading 28.6% return on capital demonstrates management’s skill in finding high-return investments
Zoetis is trading at $74.96 per share, or 10.8x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.